Post by Merck

2,749,603 followers

The European Commission has approved a new treatment combination for certain patients with muscle-invasive #bladdercancer (MIBC) – a step forward for a patient population that has faced years of limited progress. Together with Pfizer and Astellas Pharma, we remain committed to delivering treatment options to patients with bladder cancer worldwide. Learn more: go.merck.com/~1li

Post content

Video Content